3Javle MM,Cao S,Durrani FA,et al.Celecoxib and mucosal protection:translation from an anmial model to a phase I clinical trial of celecoxib,irinotecan,and 5-fluorouracil[J].Clin Cancer Res,2007,13(3):965-971. 被引量：1
4Conroy T,Hebbar M,Bennouna J,et al.Quality-of-lifefindings from a randomised phase-II study of XELOX vs FOLFOX-6 in metastatic colorectal cancer[J].Br J Cancer,2010,102(1):59. 被引量：1
5Maroun JA,Anthony LB,Blais N,et al.Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer:a consensus statement by the canadian working group on chemotherapy-induced diarrhea[J].Curr Oncol,2007,14(1):13-20. 被引量：1
6Rosenoff SH,Gabrail NY,Conklin R,et al.Amulticenter,randomized trial of long-acting octreotide for the optmium prevention of chemotherapy-induced diarrhea:results of the STOP trial[J].J Support Oncol,2006,4(6):289-294. 被引量：1
